{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:54:51Z","timestamp":1789124091638,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.maturitas.2015.06.040","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T10:02:01Z","timestamp":1437904921000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Hormone therapy and risk of venous thromboembolism among postmenopausal women"],"prefix":"10.1016","volume":"82","author":[{"given":"Marianne","family":"Canonico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.maturitas.2015.06.040_bib0005","first-page":"657","article-title":"Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP study group. Groupe d'Etude de la Thrombose de Bretagne Occidentale","volume":"83","author":"Oger","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"September (5)","key":"10.1016\/j.maturitas.2015.06.040_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MOH.0b013e32833c07bc","article-title":"Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women","volume":"17","author":"Olie","year":"2010","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.maturitas.2015.06.040_bib0015","doi-asserted-by":"crossref","unstructured":"Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center, N. Engl. J. Med. (1974) 290(1) 15\u201319.","DOI":"10.1056\/NEJM197401032900104"},{"issue":"October (9033)","key":"10.1016\/j.maturitas.2015.06.040_bib0020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","article-title":"Risk of venous thromboembolism in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"issue":"October (9033)","key":"10.1016\/j.maturitas.2015.06.040_bib0025","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"issue":"March (7083)","key":"10.1016\/j.maturitas.2015.06.040_bib0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/bmj.314.7083.796","article-title":"Hormone replacement therapy and risk of venous thromboembolism: population based case-control study","volume":"314","author":"Perez Gutthann","year":"1997","journal-title":"BMJ"},{"issue":"August (9382)","key":"10.1016\/j.maturitas.2015.06.040_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"issue":"October (13)","key":"10.1016\/j.maturitas.2015.06.040_bib0040","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1001\/jama.292.13.1581","article-title":"Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis","volume":"292","author":"Smith","year":"2004","journal-title":"JAMA"},{"issue":"May (5)","key":"10.1016\/j.maturitas.2015.06.040_bib0045","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1538-7836.2005.01268.x","article-title":"Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study","volume":"3","author":"Douketis","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"February (7)","key":"10.1016\/j.maturitas.2015.06.040_bib0050","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Estrogen, thromboembolism risk study G. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"January (1)","key":"10.1016\/j.maturitas.2015.06.040_bib0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/jth.12060","article-title":"The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy","volume":"11","author":"Roach","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"October (9033)","key":"10.1016\/j.maturitas.2015.06.040_bib0060","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(96)07308-4","article-title":"Prospective study of exogenous hormones and risk of pulmonary embolism in women","volume":"348","author":"Grodstein","year":"1996","journal-title":"Lancet"},{"issue":"October (5)","key":"10.1016\/j.maturitas.2015.06.040_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/13697130902780853","article-title":"Risk of cardiovascular outcomes in users of estradiol\/dydrogesterone or other HRT preparations","volume":"12","author":"Schneider","year":"2009","journal-title":"Climacteric"},{"issue":"2","key":"10.1016\/j.maturitas.2015.06.040_bib0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"May (4)","key":"10.1016\/j.maturitas.2015.06.040_bib0075","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2141.2010.08128.x","article-title":"Reproductive history, hormone replacement, and incidence of venous thromboembolism: the longitudinal investigation of thromboembolism etiology","volume":"149","author":"Ohira","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"May (5)","key":"10.1016\/j.maturitas.2015.06.040_bib0080","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1538-7836.2010.03839.x","article-title":"Hormone replacement therapy and the risk of venous thromboembolism: a population-based study","volume":"8","author":"Renoux","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"November (11)","key":"10.1016\/j.maturitas.2015.06.040_bib0085","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","article-title":"Million women study C. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study","volume":"10","author":"Sweetland","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"May (9)","key":"10.1016\/j.maturitas.2015.06.040_bib0090","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease: the heart and estrogen\/progestin replacement study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann. Intern. Med."},{"issue":"August (8)","key":"10.1016\/j.maturitas.2015.06.040_bib0095","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1056\/NEJM200008243430801","article-title":"Effects of estrogen replacement on the progression of coronary-artery atherosclerosis","volume":"343","author":"Herrington","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"October (17)","key":"10.1016\/j.maturitas.2015.06.040_bib0100","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa010534","article-title":"A clinical trial of estrogen-replacement therapy after ischemic stroke","volume":"345","author":"Viscoli","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"December (9350)","key":"10.1016\/j.maturitas.2015.06.040_bib0105","first-page":"2001","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","author":"Cherry","year":"2002","journal-title":"Lancet"},{"issue":"July (3)","key":"10.1016\/j.maturitas.2015.06.040_bib0110","first-page":"321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"August (7613)","key":"10.1016\/j.maturitas.2015.06.040_bib0115","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.39266.425069.AD","article-title":"Main morbidities recorded in the women\u2019s international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women","volume":"335","author":"Vickers","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2015.06.040_bib0120","series-title":"Hypercoagulable States: Fundamental Aspects, Acquired Disorders and Congenital Thrombophilia","first-page":"209","article-title":"Haemostatic variables and arterial thrombotic disease: epidemiological evidence","author":"Scarabin","year":"1996"},{"issue":"9","key":"10.1016\/j.maturitas.2015.06.040_bib0125","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"July (7)","key":"10.1016\/j.maturitas.2015.06.040_bib0130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GME.0000000000000296","article-title":"Hormone therapy and hemostasis among postmenopausal women: a review","volume":"21","author":"Canonico","year":"2014","journal-title":"Menopause"},{"issue":"May (7655)","key":"10.1016\/j.maturitas.2015.06.040_bib0135","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","article-title":"Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis","volume":"336","author":"Canonico","year":"2008","journal-title":"BMJ"},{"issue":"December (6)","key":"10.1016\/j.maturitas.2015.06.040_bib0140","first-page":"961","article-title":"Increased risk of recurrent venous thromboembolism during hormone replacement therapy\u2013results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET)","volume":"84","author":"Hoibraaten","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"October (13)","key":"10.1016\/j.maturitas.2015.06.040_bib0145","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"issue":"April (7)","key":"10.1016\/j.maturitas.2015.06.040_bib0150","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/archinte.166.7.772","article-title":"Venous thrombosis and conjugated equine estrogen in women without a uterus","volume":"166","author":"Curb","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"July (7)","key":"10.1016\/j.maturitas.2015.06.040_bib0155","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/j.1538-7836.2005.01450.x","article-title":"Genetic variation at the estrogen receptor alpha locus in relation to venous thromboembolism risk among postmenopausal women","volume":"3","author":"Straczek","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"June (6)","key":"10.1016\/j.maturitas.2015.06.040_bib0160","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","article-title":"Estrogen, group THRS obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER study","volume":"4","author":"Canonico","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"May (5)","key":"10.1016\/j.maturitas.2015.06.040_bib0165","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/gme.0b013e3181f9f7c3","article-title":"Hormone therapy and recurrence of venous thromboembolism among postmenopausal women","volume":"18","author":"Olie","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.maturitas.2015.06.040_bib0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000360554","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women","volume":"43","author":"Scarabin","year":"2014","journal-title":"Front. Horm. Res."},{"issue":"November\u2013December (6)","key":"10.1016\/j.maturitas.2015.06.040_bib0175","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/gme.0b013e3181e102eb","article-title":"Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen","volume":"17","author":"Canonico","year":"2010","journal-title":"Menopause"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512215300062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:03:13Z","timestamp":1759914193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512215300062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0378512215300062"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.06.040","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormone therapy and risk of venous thromboembolism among postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2015.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}